Skip to main content

Table 2 Comparison of different prognosticators in single studies on breast cancer.

From: Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

LN +

Prognosticator

P value

Kuopio et al. 1998 [34]

  
 

1. Bcl-2

0.017

 

2. p53

0.121

 

3. Cystatin A

0.386

Jalava et al. 2002 [16]

  
 

1. ErbB2

0.0002

 

2. SMI

0.0014

 

3. Bcl-2

0.048

Elzagheid et al. 2002 [150]

  
 

1. E-cadherin

0.0006

 

2. SMI

0.0133

LN -

  

Kuopio et al. 1998 [34]

  
 

1. Cystatin A

0.010

 

2. p53

0.021

 

3. Bcl-2

0.874

Jalava et al. 2002 [16]

  
 

1. SMI

0.0001

 

2. ErbB2

N.S.

 

3. Bcl-2

N.S.

Elzagheid et al. 2002 [150]

  
 

1. SMI

0.0299

 

2. E-cadherin

0.5581

  1. P values refer to the results of univariate analysis. Comparison of univariate analyses in a study allows one to conclude on the relative strengths of different prognosticators.